Wedge, Eileen
Ahmadov, Ulvi
Hansen, Thomas B.
Gao, Zongliang
Tulstrup, Morten https://orcid.org/0000-0002-7444-7652
Côme, Christophe https://orcid.org/0000-0001-5229-4440
Nonavinkere Srivatsan, Sridhar
Ahmed, Tanzir
Jespersen, Jakob S. https://orcid.org/0000-0002-4930-5900
Schlotmann, Balthasar C. https://orcid.org/0000-0002-8137-544X
Schöllkopf, Claudia
Raaschou-Jensen, Klas
Ødum, Niels
Kjems, Jørgen
Bak, Rasmus O. https://orcid.org/0000-0002-7383-0297
Walter, Matthew J. https://orcid.org/0000-0002-7753-1091
Grønbæk, Kirsten https://orcid.org/0000-0002-1535-9601
Kristensen, Lasse S. https://orcid.org/0000-0002-5980-7939
Funding for this research was provided by:
Novo Nordisk Fonden (NNF17CC0027852, NNF17CC0027852)
Kræftens Bekæmpelse (R223-A13071, R223-A13071)
Rigshospitalets Forskningsfond; University of Copenhagen; Greater Copenhagen Health Science Partners
Lundbeckfonden (R307-2018-3433, R307-2018-3433)
U.S. Department of Health & Human Services | National Institutes of Health (P50CA171963)
Leukemia and Lymphoma Society (7024-21)
Siteman Investment Program (5124) from Washington University; Edward P. Evans Foundation
Article History
Received: 3 October 2022
Revised: 16 February 2023
Accepted: 28 February 2023
First Online: 15 March 2023
Change Date: 24 March 2023
Change Type: Update
Change Details: Figure 1 has been corrected.
Competing interests
: The authors declare no competing interests.